|
|
|||
|
||||
OverviewThis Annals volume includes scholarly summaries of scientific achievement by winners and finalists candidates of the 2011 Prix Galien USA awards for achievement in pharmaceutical science. Contributions by GlaxoSmithKline, Amgen, Pfizer, and Janssen Biotech present advances in biotechnology and pharmaceutical agents that combat a range of diseases. NOTE: Annals volume are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632 ACADEMY MEMBERS: Please contact the New york Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Sciences receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member. Full Product DetailsAuthor: Editorial Staff of Annals of the New York Academy of SciencesPublisher: John Wiley and Sons Ltd Imprint: Wiley-Blackwell Dimensions: Width: 17.80cm , Height: 0.50cm , Length: 25.40cm Weight: 0.149kg ISBN: 9781573318587ISBN 10: 1573318582 Pages: 56 Publication Date: 05 October 2012 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Out of stock The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsAuthor InformationFor 200 yearssince 1817the Academy has brought together extraordinary people working at the frontiers of discovery. Among the oldest scientific organizations in the United States, it has become not only an enduring cultural institution in New York, but also one of the most significant organizations in the global scientific community. Tab Content 6Author Website:Countries AvailableAll regions |
||||